| Date Filed | Type | Description |
| 08/03/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 581 shares
@ $2.94, valued at
$1.7k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,212 shares
@ $3.39, valued at
$4.1k
|
|
| 05/12/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 135,000 options to buy
@ $2.77, valued at
$374k
Disposed/sold 24,999 options to buy
@ $29.4, valued at
$735k
Granted 24,999 options to buy
@ $2.77, valued at
$69.2k
Disposed/sold 15,000 options to buy
@ $59.75, valued at
$896.3k
Granted 15,000 options to buy
@ $2.77, valued at
$41.6k
Disposed/sold 29,000 options to buy
@ $41.8, valued at
$1.2M
Granted 29,000 options to buy
@ $2.77, valued at
$80.3k
Disposed/sold 56,666 options to buy
@ $10.6, valued at
$600.7k
Granted 56,666 options to buy
@ $2.77, valued at
$157k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/02/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,020 shares
@ $2.15, valued at
$2.2k
|
|
| 05/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/03/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,959 shares
@ $1.7, valued at
$3.3k
|
|
| 03/15/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,210 shares
@ $4, valued at
$4.8k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,274 shares
@ $2.85, valued at
$3.6k
|
|
| 11/21/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 200,000 options to buy
@ $2.38, valued at
$476k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 13,706 shares
@ $0.48, valued at
$6.6k
|
|
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Paid exercise price by delivering 7,729 shares
@ $0.88, valued at
$6.8k
|
|
| 04/01/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Paid exercise price by delivering 14,472 shares
@ $1.14, valued at
$16.5k
|
|
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 141,667 shares
@ $0
Granted 566,667 options to buy
@ $1.06, valued at
$600.7k
|
|
| 06/28/2021 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 72,000 shares
@ $0
Granted 290,000 options to buy
@ $4.18, valued at
$1.2M
|
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 300,000 shares
@ $0
Granted 250,000 options to buy
@ $2.94, valued at
$735k
|
|
| 04/01/2020 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 120,000 shares
@ $0
Granted 150,000 shares
@ $0
Granted 800,000 options to buy
@ $5.95, valued at
$4.8M
|
|
| 04/01/2020 |
3
| Ghosh Anirvan (CEO) has filed a Form 3 on Unity Biotechnology, Inc. |